Our Story
ClearSky Medical Diagnostics specialises in developing digital technologies for the diagnosis and monitoring of Parkinson’s, Alzheimer’s, and other neurodegenerative conditions.
Originating from a collaboration with specialists from Leeds General Infirmary, Heriot-Watt University, and the University of York, the company was incorporated in 2013 by co-founder and director Dr. Stephen Smith, along with academic and industry investors.
In response to the stagnant diagnostic landscape of neurodegenerative conditions, ClearSky was founded on the vision of transforming healthcare through modern technologies and computer science. Our mission is to provide objective tools for assessing and monitoring these conditions, addressing challenges in accessibility and introducing clarity to medical diagnoses—reflecting our name, ClearSky, in understanding neuroscience. Over the past ten years, ClearSky has created a portfolio of non-invasive devices for safe, quick, and objective symptom assessment, making them ideal for clinical diagnostics and supporting research. Leveraging broad expertise in AI & Machine Learning, wearable technologies, clinical domains, and crucial commercialization aspects like regulatory affairs and pricing, ClearSky offers tailored, comprehensive AI/Machine Learning services for healthcare professionals and industry stakeholders seeking digital technology solutions.
Management Team
Prof Stephen Smith
Managing Director
Stephen Smith is the Co-Founder and Director of ClearSky and the Head of School of Physics, Engineering and Technology at the University of York. Stephen’s research focuses on the diagnosis, differentiation, and monitoring of neurodegenerative conditions such as Parkinson’s and Alzheimer’s. His dedication to translating technology from theoretical studies to widespread clinical adoption has fostered collaborations with consultant neurologists and specialist nurses, leading to the development of innovative and unique medical equipment for these conditions.
.png)
Harvey Dettmar
Finance Director
Harvey Dettmar has a background in technology and investment banking with a first class honour’s degree in Information Technology and an MBA with merit. Since 2003 Harvey has created and worked for a number of healthcare start-up companies in finance, operations and sales. Harvey also has valuable experience in selling to the NHS in the UK and developing and managing international distributors and partners.
.png)
Betty Su
Market Access Director
Betty Su leads the regulatory affairs and market access strategies at ClearSky, playing a pivotal role in supporting our industry customers and partners in incorporating AI into the current standard of care. With 25 years of industry and consulting experience, Betty has an extensive background spanning the drug, device, and diagnostic technology sectors.
Alex Lou
Commercial Director
Alex Lou spearheads ClearSky’s commercial and business development initiatives, leveraging 30 years of entrepreneurial expertise in fundraising, sales generation, and distributor management within the field of medical innovations. As a strategic leader, Alex has successfully driven large-scale investment fundraising campaigns and acted as an angel investor for numerous start-ups.
AI and Machine Learning Team
.png)
Chief Scientific Officer
Dr Michael Lones
Michael is Associate Professor in the School of Mathematical and Computer Sciences, Heriot-Watt University, Edinburgh. His research covers topics in optimisation, data mining, medical informatics, systems biology and non-standard computation. His current work includes the diagnosis and understanding of neurodegenerative diseases, and the use of artificial biochemical networks for controlling robots and other complex systems.
.png)
Head of Product Development
Dr Cameron Harwood
TBA
.png)
Head of Machine Learning
Dr Marta Vallejo
As Head of Machine Learning, Marta Vallejo leads the integration of advanced machine learning techniques in healthcare solutions, with a focus on neurodegenerative disease diagnostics. With over a decade of experience, Marta specialises in developing and applying deep learning models that utilise diverse datasets to improve diagnosis and treatment in conditions such as Parkinson's, Huntington's and ALS. Marta is also an Assistant Professor at Heriot-Watt University and the founder of the ML-Health research group, a multidisciplinary team dedicated to pioneering machine learning in healthcare. Her extensive research and collaborations bridge academia and industry, contributing to advances in personalised medicine and early diagnostic tools.
.png)
Software Engineer -
AI and Machine Learning
Dr Victoria Hodge
TBA
.png)
Software Engineer -
AI and Machine Learning
Dr Iris Kyranou
TBA
Medical Advisers
.png)
DR STUART JAMIESON
Dr Jamieson has been a Consultant Neurologist at Leeds General Infirmary and Senior Lecturer in Neurology at the University of Leeds for more than twenty years. He is the senior member of the Yorkshire Movement Disorders Service and has extensive experience and knowledge of Parkinson’s disease, Huntington’s disease, dystonia and tremor managing thousands of patients with these disorders over the years.
.png)
DR JANE ALTY
Dr Alty is a Senior Lecturer in Neurology at Wicking Dementia Research & Education Centre at the University of Tasmania. Her previous role was Consultant Neurologist at Leeds Teaching Hospitals NHS Trust. She is a shareholder in ClearSky MD and was part of the team that won an international award from Hummies (prize money) for work on Parkinson’s dyskinesia.
.png)
DR SHENGDI CHEN
Professor Chen is the Chairman of the Department of Neurology at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. His interests focus on the epidemiology, pathogenesis, diagnosis and treatment of Parkinson's disease, Alzheimer's disease and related disorders. Professor Chen has published 450 original and review articles (including more than 90 SCI papers) and has rich experience in serving as editorial board members and reviewers for various journals across the field.
Get in Touch
ClearSky Medical Diagnostics
The Catalyst
Baird Lane
York
YO10 5GA
info@clearskymd.com
+44 (0)1904 322351
